Ledger.Open graph →
SEC Form D · filed January 5, 2023

Urica Therapeutics, Inc

Offering
$5.0M
Sold
$2.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BAY HARBOR ISLANDS, FL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Michael S. Weiss · Burlington, MADirectorRaymond S. Zheng · Bay Harbor Islands, FLExec · DirectorJay D. Kranzler, M.D., Ph.D · Bay Harbor Islands, FLExec · DirectorVibeke S. Strand, M.D · Bay Harbor Islands, FLDirectorLindsay A. Rosenwald, M.D · New York, NYDirectorRaymond S. Zheng · Bay Harbor Islands, FLExec · DirectorJay D. Kranzler, M.D., Ph.D · Bay Harbor Islands, FLExec · DirectorMichael S. Weiss · NEW YORK, NYDirectorVibeke S. Strand, M.D · Bay Harbor Islands, FLDirectorLindsay A. Rosenwald, M.D · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗